Haohua Chemical Science & Technology Corp Ltd (600378) fair value: what the stock is really worth
As of Nov 5, 2026: fair value (intrinsic value) of Haohua Chemical Science & Technology Corp Ltd stock ¥17.47, price ¥34.27, that is 49.0% below the price, quality 43 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.
How to read this chart
60‑month range ¥19.38 – ¥82.17 · fair‑value band ¥10.49 – ¥22.41 · the ¥34.27 price screens above the ¥17.47 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.
Follow Haohua Chemical Science & Technology Corp in your weekly email
Every Wednesday you see whether Haohua Chemical Science & Technology Corp is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Haohua Chemical Science & Technology Corp., Ltd. engages in the research and development, production, and sales of manufactures and sells fluorine materials, electronic gases, high-end manufacturing chemical materials, and carbon emission reduction products in China and internationally.
Show moreShow less
The company offers Grease, new fluorine rubber and fluorine compound rubber, tetrafluoropropanol, perfluoropropylene, tetrafluoroethylene monomer, etc., and engineering rubber products and rubber molded products, such as shield segment elastic rubber gaskets, water-swellable rubber seals, rubber seals for water supply and drainage pipes, and cement pipe jacking, etc.
In addition, the company offers composite materials or pouring system materials for use in automobiles, construction, home furnishing, metallurgy, energy, electronic power, sports, clothing, printing, etc.; special coating products, including marine coatings, industrial heavy-duty anti-corrosion coatings, aircraft coatings, and other special functional materials; and carbon emission reduction technologies and services.
The company was formerly known as Sichuan Tianyi Science & Technology Co., Ltd. and changed its name to Haohua Chemical Science & Technology Corp., Ltd. in June 2019. The company was founded in 1999 and is based in Chengdu, the People's Republic of China.
Stock analysis
Haohua Chemical Science & Technology Corp Ltd (600378) currently trades at ¥34.27, while our model-based Fair Value estimate is ¥17.47, 49% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ¥20.71 per share, and 2 of the 26 models we run sit above the ¥34.27 price.
Bear case: the Dividend Discount group reads lowest at ¥6.39, and 24 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: ¥10.49 (bear) to ¥22.41 (bull), the price of ¥34.27 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 43/100 (below-average quality), in the Basic Materials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Haohua Chemical Science & Technology Corp Ltd reported revenue of 16.7B CNY in FY2025 versus 7.4B CNY in FY2021, a compound +22.4%/yr. Reported net income was 1.4B CNY in FY2025, compounding +12.8%/yr from FY2021.
Key figures
Market cap 44.2B CNY (≈ $6.6B) Mid · P/E ratio 26.2 · P/S ratio 2.37 · EPS (TTM) ¥1.31 · Dividend yield 1.1% · Net margin 9.1% · Return on equity 10.6% · Return on assets (EBIT) 6.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 45 out of 100 (low confidence).
What moves the price
The share trades about 58% below its 52-week high and 18% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −17% fair-value upside, at −49%, 600378 screens richer than that median.
Fair Value models
Bear¥10.49Fair Value ¥17.47Bull¥22.41
Price ¥34.27 · Downside -49.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (¥0.7797 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF¥6.88¥10.64¥17.1179
Growth DCF¥6.80¥10.10¥15.5178
Owner Earnings¥4.69¥6.59¥9.8776
All 26 models by family
DCF Models
FCF DCF¥6.88¥10.64¥17.1179
Owner Earnings¥4.69¥6.59¥9.8776
5Y Revenue Exit¥12.71¥22.90¥37.3571
5Y EBITDA Exit¥15.30¥28.40¥45.4973
5Y P/E Exit¥12.79¥23.08¥35.2969
10Y Revenue Exit¥10.20¥19.10¥33.8564
10Y EBITDA Exit¥12.34¥23.09¥40.6766
10Y P/E Exit¥10.70¥19.23¥32.1362
Earnings-Based
Graham-Dodd¥7.61¥38.87¥53.7064
Lynch FV¥10.58¥15.12¥19.6561
PEG = 1.0¥10.58¥15.12¥19.6557
EPV¥14.17¥16.00¥17.5874
Dividend Discount
Gordon GGM¥3.73¥7.36¥11.0467
DDM Multi-Stage¥3.73¥6.39¥7.7867
Multiples
P/E Multiple¥14.28¥19.04¥23.7963
P/S Multiple¥14.28¥19.04¥23.7958
P/B Multiple¥28.99¥38.65¥48.3155
EV/EBIT¥17.08¥22.16¥27.2366
EV/EBITDA¥20.15¥26.25¥32.3567
EV/Revenue¥15.05¥20.71¥26.3654
Asset-Based
NCAV (Graham)¥0.2300¥0.3500¥0.440054
Growth DCF
Growth DCF¥6.80¥10.10¥15.5178
Rev-Margin DCF¥12.71¥22.41¥35.3171
Economic Profit
Residual Income¥11.54¥12.27¥13.6876
ROIC Compounder¥14.19¥18.15¥22.3572
Growth Earnings
Growth-Adj P/E¥14.39¥20.55¥26.7267
The fair value above starts from this blend and is adjusted for dilution from new shares.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+19.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+22.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+25.2%
Start year 2020 (pandemic). Over 10 years: +42.8% a year
Revenue growth 28 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.4%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+10.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year+9.2%
Dividend (yield on the price)1.1%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.9.2% vs 22.3%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.12% → 11%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+41.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+11.9%
Yearly sales growth analysts expect, extended to five years.
After inflation (China: IMF forecast 1.7% a year to 2030, 1.4% from 2016 to 2025) that is about +39.2% a year for the price and +10.1% for the forecasts.
AI conclusion: Leading positions in electronic gases and high-end fluoropolymers form the main strength, yet the commoditized sector without a clear durable moat limits sustained margin gains.
Main risk: Slower projected growth in the chemicals industry would cap upside from the fluorine chemicals segment and prevent lasting margin expansion.
Haohua's fluorine chemicals segment posted solid first-half gains as refrigerants and lithium battery materials saw both higher volumes and prices amid steadier supply-demand balances. Our models still view the shares as overvalued despite the steep drop from the 52-week high. Will the company's leading positions in electronic gases and high-end fluoropolymers deliver lasting margin expansion, or will the chemicals industry's slower projected growth cap the upside?
Compare Haohua Chemical Science & Technology Corp Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 340 stocks
Beats the industry median on 5/14 measures
Overall it trails its industry peers.
Valuation
Quality Score43 · Below median
Fair Value upside−49.0% · Below median
Profitability
Return on equity (12 months)10.6% · Above median
Return on assets4.6% · Above median
Net margin (12 months)9.1% · Above median
Operating margin (12 months)13.0% · Above median
Growth and dividend
Revenue growth (quarter YoY)18.6% · Above median
Dividend yield (12 months)1.1% · Below median
Balance sheet
Debt / equity0.14× · Above median
Valuation Multiplesvs Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Haohua Chemical Science & Technology Corp Ltd Fair Value". https://www.fairvalue-calculator.com/stock/600378
Frequently asked questions
Is Haohua Chemical Science & Technology Corp Ltd (600378) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of ¥17.47 versus a price of ¥34.27, about 49% lower (overvalued).
What is the fair value of 600378?
Our model-based fair value for Haohua Chemical Science & Technology Corp Ltd is ¥17.47 (as of Nov 6, 2026), built from audited fundamentals. The current price: ¥34.27.
What is the quality score of 600378?
Haohua Chemical Science & Technology Corp Ltd has a Quality Score of 43/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Haohua Chemical Science & Technology Corp Ltd (600378)?
Our model-based price target is the fair value of ¥17.47 (as of Nov 6, 2026) from 26 valuation models. Cautious scenario ¥10.49, optimistic scenario ¥22.41. It is a calculation from audited fundamentals, not an analyst target.
What is the Haohua Chemical Science & Technology Corp Ltd stock forecast for 2026?
Our models put fair value at ¥17.47, about 49% lower versus a price of ¥34.27 (overvalued). Cautious scenario ¥10.49, optimistic scenario ¥22.41. The calculation is refreshed regularly with new filings.
What is the revenue of Haohua Chemical Science & Technology Corp Ltd (600378)?
Haohua Chemical Science & Technology Corp Ltd reported trailing-twelve-month revenue of about 18.6B CNY (latest available figure, as of Nov 6, 2026).
Does Haohua Chemical Science & Technology Corp Ltd pay a dividend?
Haohua Chemical Science & Technology Corp Ltd currently shows a dividend yield of 1.14% relative to its recent price (as of Nov 6, 2026).
What growth is priced into Haohua Chemical Science & Technology Corp Ltd (600378)?
For today's price to be fair in a discounted-cash-flow model, Haohua Chemical Science & Technology Corp Ltd would have to grow free cash flow by +41.5 % per year for five years (discount rate 9.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +25.2 % per year. As of Nov 6, 2026.
What discount rate (WACC) does the fair value of 600378 use?
Our models discount Haohua Chemical Science & Technology Corp Ltd at 9.6 %: a base by market capitalisation (mid), damped by beta 0.69, country premium for China. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Haohua Chemical Science & Technology Corp Ltd that is +41.5 % per year a year over ten years, using the same discount rate (9.6 %) and the same formula as our fair value.
How much growth has Haohua Chemical Science & Technology Corp Ltd (600378) delivered so far?
Over the past 5 years revenue at Haohua Chemical Science & Technology Corp Ltd grew +25.2 % a year. The price currently implies +41.5 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Haohua Chemical Science & Technology Corp Ltd (600378) growing?
The median revenue growth in the sector is +9.8 % a year. That is the yardstick for the growth priced into Haohua Chemical Science & Technology Corp Ltd (+41.5 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Haohua Chemical Science & Technology Corp Ltd (600378)?
The free-cash-flow yield on the price is 0.91 %: that much free cash flow Haohua Chemical Science & Technology Corp Ltd produces per unit of market value. When it exceeds the discount rate of our models (9.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Haohua Chemical Science & Technology Corp Ltd (600378)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Haohua Chemical Science & Technology Corp Ltd it is ¥17.47 per share (as of Nov 6, 2026), against a price of ¥34.27. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Haohua Chemical Science & Technology Corp Ltd stock overvalued or undervalued in 2026?
As of Nov 6, 2026, 600378 trades above its calculated fair value: price ¥34.27, fair value ¥17.47, a gap of about −49% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 600378?
No. The price is what the market pays today (¥34.27); the fair value is what the company's own numbers justify (¥17.47). For Haohua Chemical Science & Technology Corp Ltd the two are ¥16.80 per share apart. That gap is exactly why we show both numbers side by side.
How much is Haohua Chemical Science & Technology Corp Ltd worth?
The market values Haohua Chemical Science & Technology Corp Ltd at about 44.2B CNY (market capitalisation, as of Nov 6, 2026). Per share that is ¥34.27; our models calculate a fair value of ¥17.47 per share.
What do the bullish and bearish scenarios say about 600378?
Our models span a range for Haohua Chemical Science & Technology Corp Ltd: cautious scenario ¥10.49, base ¥17.47, optimistic ¥22.41 per share (as of Nov 6, 2026, price ¥34.27). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 600378?
Haohua Chemical Science & Technology Corp Ltd trades at a price-to-earnings ratio of 26.2 (as of Nov 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥17.47 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings, FY2025 ex one-offs: 30.3. Other multiples: P/B 2.4, P/S 2.4, EV/EBITDA 12.0.
How solid is the balance sheet of Haohua Chemical Science & Technology Corp Ltd (600378)?
Balance-sheet figures for Haohua Chemical Science & Technology Corp Ltd (as of Nov 6, 2026): return on equity 10.6%, debt of 0.14 per unit of equity. They feed the Quality Score of 43/100, which measures business quality independently of the share price.
How far is 600378 from its 52-week high?
Haohua Chemical Science & Technology Corp Ltd trades at ¥34.27, about 58% below its 52-week high of ¥82.17 and 18% above the low of ¥29.11 (as of Nov 5, 2026). Distance from the high says nothing about value: that is what the fair value of ¥17.47 is for.
Which stocks are comparable to Haohua Chemical Science & Technology Corp Ltd?
From the same area (Basic Materials) we also value BASF SE, Dow Inc, Ningxia Baofeng Energy Group, Zangge Mining Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Haohua Chemical Science & Technology Corp Ltd stock attractive at the current price?
The data as of Nov 6, 2026: price ¥34.27, calculated fair value ¥17.47 (−49%), Quality Score 43/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 600378 calculated?
We run Haohua Chemical Science & Technology Corp Ltd through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥17.47, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.5% above its aggregate fair value. Haohua Chemical Science & Technology Corp Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Haohua Chemical Science & Technology Corp Ltd (600378)?
The closing price on Nov 5, 2026 was ¥34.27. Our model-based fair value is ¥17.47, about 49% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Haohua Chemical Science & Technology Corp Ltd right now?
The price sits above even our optimistic bull case (¥22.41). The favourable scenario is already priced in. Weak quality (43/100) and above fair value at the same time, the margin of safety is missing on both counts. A fairly wide model range (¥10.49 to ¥22.41) leaves room in how you read the outcome.
Where does the earnings growth of Haohua Chemical Science & Technology Corp Ltd (600378) come from?
Earnings per share at Haohua Chemical Science & Technology Corp Ltd grew +20.3 % a year from 2013 to 2024. Broken into its drivers: revenue per share +23.0 %, EBIT margin −2.2 %, tax rate −0.1 %, residual (interest, one-offs) +0.2 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Haohua Chemical Science & Technology Corp Ltd
How large is the market capitalisation of Haohua Chemical Science & Technology Corp Ltd (600378)?
The market capitalisation of Haohua Chemical Science & Technology Corp Ltd is 44.2B CNY (≈ $6.6B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Haohua Chemical Science & Technology Corp Ltd (600378)?
The price-to-sales ratio of Haohua Chemical Science & Technology Corp Ltd is 2.37 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Haohua Chemical Science & Technology Corp Ltd (600378)?
Earnings per share at Haohua Chemical Science & Technology Corp Ltd are ¥1.31 (price ÷ EPS = P/E 26.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Haohua Chemical Science & Technology Corp Ltd (600378)?
The dividend yield of Haohua Chemical Science & Technology Corp Ltd is 1.1% (payout 29.9%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Haohua Chemical Science & Technology Corp Ltd (600378)?
The net margin of Haohua Chemical Science & Technology Corp Ltd is 9.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Haohua Chemical Science & Technology Corp Ltd (600378)?
The return on equity (ROE) of Haohua Chemical Science & Technology Corp Ltd is 10.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Haohua Chemical Science & Technology Corp Ltd (600378)?
On an EBIT basis the return on assets of Haohua Chemical Science & Technology Corp Ltd is 6.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Haohua Chemical Science & Technology Corp Ltd (600378)?
The operating margin of Haohua Chemical Science & Technology Corp Ltd is 13.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Haohua Chemical Science & Technology Corp Ltd (600378)?
Revenue at Haohua Chemical Science & Technology Corp Ltd is growing +18.6% versus a year earlier (3y avg +22.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Haohua Chemical Science & Technology Corp Ltd (600378)?
Earnings per share at Haohua Chemical Science & Technology Corp Ltd are growing +29.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Haohua Chemical Science & Technology Corp Ltd (600378) hold?
Haohua Chemical Science & Technology Corp Ltd holds more cash than debt, 2.4B CNY net (fiscal year 2024). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Haohua Chemical Science & Technology Corp Ltd in the live analysis
One click puts Haohua Chemical Science & Technology Corp Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 6, 2026